Early research (Phase 1)Study completedNCT02094729
What this trial is testing
A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease
Who this might be right for
Alzheimer's Disease
Eisai Co., Ltd. 26